Mesirow Financial Investment Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Mesirow Financial Investment Management’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-31,632	Closed	-$260K	–	100
2021 Q2	$260K	Buy	31,632 +113	+0.4%	+$961	0.66%	79
2021 Q1	$282K	Sell	31,519 -988	-3%	-$11.3K	0.77%	72
2020 Q4	$375K	Buy	32,507 +136	+0.4%	+$1.58K	1.19%	55
2020 Q3	$337K	Buy	32,371 +185	+0.6%	+$2.27K	1.44%	29
2020 Q2	$423K	Sell	32,186 -5,967	-16%	-$61.9K	1.99%	4
2020 Q1	$300K	Buy	+38,153	New	+$575K	1.89%	4

Other funds holding FLXN

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Clearline Capital New York $1.29B AUM 38.13% 1-Year Est. Return

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return